Serveur d'exploration sur la glutarédoxine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta.

Identifieur interne : 000D56 ( Main/Exploration ); précédent : 000D55; suivant : 000D57

Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta.

Auteurs : Niki L. Reynaert [États-Unis] ; Albert Van Der Vliet ; Amy S. Guala ; Toby Mcgovern ; Milena Hristova ; Cristen Pantano ; Nicholas H. Heintz ; John Heim ; Ye-Shih Ho ; Dwight E. Matthews ; Emiel F M. Wouters ; Yvonne M W. Janssen-Heininger

Source :

RBID : pubmed:16916935

Descripteurs français

English descriptors

Abstract

The transcription factor NF-kappaB, a central regulator of immunity, is subject to regulation by redox changes. We now report that cysteine-179 of the inhibitory kappaB kinase (IKK) beta-subunit of the IKK signalosome is a central target for oxidative inactivation by means of S-glutathionylation. S-glutathionylation of IKK-beta Cys-179 is reversed by glutaredoxin (GRX), which restores kinase activity. Conversely, GRX1 knockdown sensitizes cells to oxidative inactivation of IKK-beta and dampens TNF-alpha-induced IKK and NF-kappaB activation. Primary tracheal epithelial cells from Glrx1-deficient mice display reduced NF-kappaB DNA binding, RelA nuclear translocation, and MIP-2 (macrophage inflammatory protein 2) and keratinocyte-derived chemokine production in response to LPS. Collectively, these findings demonstrate the physiological relevance of the S-glutathionylation-GRX redox module in controlling the magnitude of activation of the NF-kappaB pathway.

DOI: 10.1073/pnas.0603290103
PubMed: 16916935
PubMed Central: PMC1559757


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta.</title>
<author>
<name sortKey="Reynaert, Niki L" sort="Reynaert, Niki L" uniqKey="Reynaert N" first="Niki L" last="Reynaert">Niki L. Reynaert</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pathology and Chemistry, University of Vermont, Burlington, 05405, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology and Chemistry, University of Vermont, Burlington, 05405</wicri:regionArea>
<wicri:noRegion>05405</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Van Der Vliet, Albert" sort="Van Der Vliet, Albert" uniqKey="Van Der Vliet A" first="Albert" last="Van Der Vliet">Albert Van Der Vliet</name>
</author>
<author>
<name sortKey="Guala, Amy S" sort="Guala, Amy S" uniqKey="Guala A" first="Amy S" last="Guala">Amy S. Guala</name>
</author>
<author>
<name sortKey="Mcgovern, Toby" sort="Mcgovern, Toby" uniqKey="Mcgovern T" first="Toby" last="Mcgovern">Toby Mcgovern</name>
</author>
<author>
<name sortKey="Hristova, Milena" sort="Hristova, Milena" uniqKey="Hristova M" first="Milena" last="Hristova">Milena Hristova</name>
</author>
<author>
<name sortKey="Pantano, Cristen" sort="Pantano, Cristen" uniqKey="Pantano C" first="Cristen" last="Pantano">Cristen Pantano</name>
</author>
<author>
<name sortKey="Heintz, Nicholas H" sort="Heintz, Nicholas H" uniqKey="Heintz N" first="Nicholas H" last="Heintz">Nicholas H. Heintz</name>
</author>
<author>
<name sortKey="Heim, John" sort="Heim, John" uniqKey="Heim J" first="John" last="Heim">John Heim</name>
</author>
<author>
<name sortKey="Ho, Ye Shih" sort="Ho, Ye Shih" uniqKey="Ho Y" first="Ye-Shih" last="Ho">Ye-Shih Ho</name>
</author>
<author>
<name sortKey="Matthews, Dwight E" sort="Matthews, Dwight E" uniqKey="Matthews D" first="Dwight E" last="Matthews">Dwight E. Matthews</name>
</author>
<author>
<name sortKey="Wouters, Emiel F M" sort="Wouters, Emiel F M" uniqKey="Wouters E" first="Emiel F M" last="Wouters">Emiel F M. Wouters</name>
</author>
<author>
<name sortKey="Janssen Heininger, Yvonne M W" sort="Janssen Heininger, Yvonne M W" uniqKey="Janssen Heininger Y" first="Yvonne M W" last="Janssen-Heininger">Yvonne M W. Janssen-Heininger</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16916935</idno>
<idno type="pmid">16916935</idno>
<idno type="doi">10.1073/pnas.0603290103</idno>
<idno type="pmc">PMC1559757</idno>
<idno type="wicri:Area/Main/Corpus">000D23</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000D23</idno>
<idno type="wicri:Area/Main/Curation">000D23</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000D23</idno>
<idno type="wicri:Area/Main/Exploration">000D23</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta.</title>
<author>
<name sortKey="Reynaert, Niki L" sort="Reynaert, Niki L" uniqKey="Reynaert N" first="Niki L" last="Reynaert">Niki L. Reynaert</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pathology and Chemistry, University of Vermont, Burlington, 05405, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology and Chemistry, University of Vermont, Burlington, 05405</wicri:regionArea>
<wicri:noRegion>05405</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Van Der Vliet, Albert" sort="Van Der Vliet, Albert" uniqKey="Van Der Vliet A" first="Albert" last="Van Der Vliet">Albert Van Der Vliet</name>
</author>
<author>
<name sortKey="Guala, Amy S" sort="Guala, Amy S" uniqKey="Guala A" first="Amy S" last="Guala">Amy S. Guala</name>
</author>
<author>
<name sortKey="Mcgovern, Toby" sort="Mcgovern, Toby" uniqKey="Mcgovern T" first="Toby" last="Mcgovern">Toby Mcgovern</name>
</author>
<author>
<name sortKey="Hristova, Milena" sort="Hristova, Milena" uniqKey="Hristova M" first="Milena" last="Hristova">Milena Hristova</name>
</author>
<author>
<name sortKey="Pantano, Cristen" sort="Pantano, Cristen" uniqKey="Pantano C" first="Cristen" last="Pantano">Cristen Pantano</name>
</author>
<author>
<name sortKey="Heintz, Nicholas H" sort="Heintz, Nicholas H" uniqKey="Heintz N" first="Nicholas H" last="Heintz">Nicholas H. Heintz</name>
</author>
<author>
<name sortKey="Heim, John" sort="Heim, John" uniqKey="Heim J" first="John" last="Heim">John Heim</name>
</author>
<author>
<name sortKey="Ho, Ye Shih" sort="Ho, Ye Shih" uniqKey="Ho Y" first="Ye-Shih" last="Ho">Ye-Shih Ho</name>
</author>
<author>
<name sortKey="Matthews, Dwight E" sort="Matthews, Dwight E" uniqKey="Matthews D" first="Dwight E" last="Matthews">Dwight E. Matthews</name>
</author>
<author>
<name sortKey="Wouters, Emiel F M" sort="Wouters, Emiel F M" uniqKey="Wouters E" first="Emiel F M" last="Wouters">Emiel F M. Wouters</name>
</author>
<author>
<name sortKey="Janssen Heininger, Yvonne M W" sort="Janssen Heininger, Yvonne M W" uniqKey="Janssen Heininger Y" first="Yvonne M W" last="Janssen-Heininger">Yvonne M W. Janssen-Heininger</name>
</author>
</analytic>
<series>
<title level="j">Proceedings of the National Academy of Sciences of the United States of America</title>
<idno type="ISSN">0027-8424</idno>
<imprint>
<date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>Cells, Cultured (MeSH)</term>
<term>Chemokine CXCL2 (MeSH)</term>
<term>Chemokines (biosynthesis)</term>
<term>Cysteine (metabolism)</term>
<term>Glutaredoxins (MeSH)</term>
<term>Glutathione (metabolism)</term>
<term>Hydrogen Peroxide (pharmacology)</term>
<term>I-kappa B Kinase (antagonists & inhibitors)</term>
<term>Keratinocytes (cytology)</term>
<term>Keratinocytes (drug effects)</term>
<term>Lipopolysaccharides (immunology)</term>
<term>Mice (MeSH)</term>
<term>Mice, Inbred C57BL (MeSH)</term>
<term>Monokines (metabolism)</term>
<term>NF-kappa B (metabolism)</term>
<term>Oxidation-Reduction (drug effects)</term>
<term>Oxidoreductases (deficiency)</term>
<term>Oxidoreductases (metabolism)</term>
<term>Protein Subunits (metabolism)</term>
<term>Respiratory System (cytology)</term>
<term>Respiratory System (drug effects)</term>
<term>Sulfenic Acids (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acides sulféniques (métabolisme)</term>
<term>Animaux (MeSH)</term>
<term>Appareil respiratoire (cytologie)</term>
<term>Appareil respiratoire (effets des médicaments et des substances chimiques)</term>
<term>Cellules cultivées (MeSH)</term>
<term>Chimiokine CXCL2 (MeSH)</term>
<term>Chimiokines (biosynthèse)</term>
<term>Cystéine (métabolisme)</term>
<term>Facteur de transcription NF-kappa B (métabolisme)</term>
<term>Glutarédoxines (MeSH)</term>
<term>Glutathion (métabolisme)</term>
<term>I-kappa B Kinase (antagonistes et inhibiteurs)</term>
<term>Kératinocytes (cytologie)</term>
<term>Kératinocytes (effets des médicaments et des substances chimiques)</term>
<term>Lipopolysaccharides (immunologie)</term>
<term>Monokines (métabolisme)</term>
<term>Oxidoreductases (déficit)</term>
<term>Oxidoreductases (métabolisme)</term>
<term>Oxydoréduction (effets des médicaments et des substances chimiques)</term>
<term>Peroxyde d'hydrogène (pharmacologie)</term>
<term>Souris (MeSH)</term>
<term>Souris de lignée C57BL (MeSH)</term>
<term>Sous-unités de protéines (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>I-kappa B Kinase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Chemokines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="deficiency" xml:lang="en">
<term>Oxidoreductases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Lipopolysaccharides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Cysteine</term>
<term>Glutathione</term>
<term>Monokines</term>
<term>NF-kappa B</term>
<term>Oxidoreductases</term>
<term>Protein Subunits</term>
<term>Sulfenic Acids</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Hydrogen Peroxide</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Chemokine CXCL2</term>
<term>Glutaredoxins</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>I-kappa B Kinase</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr">
<term>Chimiokines</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr">
<term>Appareil respiratoire</term>
<term>Kératinocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Keratinocytes</term>
<term>Respiratory System</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Keratinocytes</term>
<term>Oxidation-Reduction</term>
<term>Respiratory System</term>
</keywords>
<keywords scheme="MESH" qualifier="déficit" xml:lang="fr">
<term>Oxidoreductases</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Appareil respiratoire</term>
<term>Kératinocytes</term>
<term>Oxydoréduction</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Lipopolysaccharides</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Acides sulféniques</term>
<term>Cystéine</term>
<term>Facteur de transcription NF-kappa B</term>
<term>Glutathion</term>
<term>Monokines</term>
<term>Oxidoreductases</term>
<term>Sous-unités de protéines</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Peroxyde d'hydrogène</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cells, Cultured</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cellules cultivées</term>
<term>Chimiokine CXCL2</term>
<term>Glutarédoxines</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The transcription factor NF-kappaB, a central regulator of immunity, is subject to regulation by redox changes. We now report that cysteine-179 of the inhibitory kappaB kinase (IKK) beta-subunit of the IKK signalosome is a central target for oxidative inactivation by means of S-glutathionylation. S-glutathionylation of IKK-beta Cys-179 is reversed by glutaredoxin (GRX), which restores kinase activity. Conversely, GRX1 knockdown sensitizes cells to oxidative inactivation of IKK-beta and dampens TNF-alpha-induced IKK and NF-kappaB activation. Primary tracheal epithelial cells from Glrx1-deficient mice display reduced NF-kappaB DNA binding, RelA nuclear translocation, and MIP-2 (macrophage inflammatory protein 2) and keratinocyte-derived chemokine production in response to LPS. Collectively, these findings demonstrate the physiological relevance of the S-glutathionylation-GRX redox module in controlling the magnitude of activation of the NF-kappaB pathway.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">16916935</PMID>
<DateCompleted>
<Year>2006</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0027-8424</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>103</Volume>
<Issue>35</Issue>
<PubDate>
<Year>2006</Year>
<Month>Aug</Month>
<Day>29</Day>
</PubDate>
</JournalIssue>
<Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
<ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation>
</Journal>
<ArticleTitle>Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta.</ArticleTitle>
<Pagination>
<MedlinePgn>13086-91</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The transcription factor NF-kappaB, a central regulator of immunity, is subject to regulation by redox changes. We now report that cysteine-179 of the inhibitory kappaB kinase (IKK) beta-subunit of the IKK signalosome is a central target for oxidative inactivation by means of S-glutathionylation. S-glutathionylation of IKK-beta Cys-179 is reversed by glutaredoxin (GRX), which restores kinase activity. Conversely, GRX1 knockdown sensitizes cells to oxidative inactivation of IKK-beta and dampens TNF-alpha-induced IKK and NF-kappaB activation. Primary tracheal epithelial cells from Glrx1-deficient mice display reduced NF-kappaB DNA binding, RelA nuclear translocation, and MIP-2 (macrophage inflammatory protein 2) and keratinocyte-derived chemokine production in response to LPS. Collectively, these findings demonstrate the physiological relevance of the S-glutathionylation-GRX redox module in controlling the magnitude of activation of the NF-kappaB pathway.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Reynaert</LastName>
<ForeName>Niki L</ForeName>
<Initials>NL</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology and Chemistry, University of Vermont, Burlington, 05405, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van der Vliet</LastName>
<ForeName>Albert</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Guala</LastName>
<ForeName>Amy S</ForeName>
<Initials>AS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>McGovern</LastName>
<ForeName>Toby</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hristova</LastName>
<ForeName>Milena</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pantano</LastName>
<ForeName>Cristen</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Heintz</LastName>
<ForeName>Nicholas H</ForeName>
<Initials>NH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Heim</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ho</LastName>
<ForeName>Ye-Shih</ForeName>
<Initials>YS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Matthews</LastName>
<ForeName>Dwight E</ForeName>
<Initials>DE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wouters</LastName>
<ForeName>Emiel F M</ForeName>
<Initials>EF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Janssen-Heininger</LastName>
<ForeName>Yvonne M W</ForeName>
<Initials>YM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 HL060812</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P20 RR015557</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL060014</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P20 RL15557</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL60014</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL074295</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>HL60812</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P01 HL074295</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2006</Year>
<Month>08</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
<NlmUniqueID>7505876</NlmUniqueID>
<ISSNLinking>0027-8424</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054426">Chemokine CXCL2</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018925">Chemokines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C516006">Glrx protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054477">Glutaredoxins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015846">Monokines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D021122">Protein Subunits</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013434">Sulfenic Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>BBX060AN9V</RegistryNumber>
<NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.-</RegistryNumber>
<NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.10</RegistryNumber>
<NameOfSubstance UI="D051550">I-kappa B Kinase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>GAN16C9B8O</RegistryNumber>
<NameOfSubstance UI="D005978">Glutathione</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>K848JZ4886</RegistryNumber>
<NameOfSubstance UI="D003545">Cysteine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054426" MajorTopicYN="N">Chemokine CXCL2</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018925" MajorTopicYN="N">Chemokines</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003545" MajorTopicYN="N">Cysteine</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054477" MajorTopicYN="N">Glutaredoxins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005978" MajorTopicYN="N">Glutathione</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051550" MajorTopicYN="N">I-kappa B Kinase</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015603" MajorTopicYN="N">Keratinocytes</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015846" MajorTopicYN="N">Monokines</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName>
<QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D021122" MajorTopicYN="N">Protein Subunits</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012137" MajorTopicYN="N">Respiratory System</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013434" MajorTopicYN="N">Sulfenic Acids</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2006</Year>
<Month>8</Month>
<Day>19</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2006</Year>
<Month>9</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2006</Year>
<Month>8</Month>
<Day>19</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">16916935</ArticleId>
<ArticleId IdType="pii">0603290103</ArticleId>
<ArticleId IdType="doi">10.1073/pnas.0603290103</ArticleId>
<ArticleId IdType="pmc">PMC1559757</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Nature. 2000 Jan 6;403(6765):103-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10638762</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>In Vitro. 1982 Sep;18(9):800-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6757109</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2000 Nov 17;275(46):36062-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10967126</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem J. 2001 Apr 1;355(Pt 1):145-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11256959</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2001 Jul 13;276(28):26269-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11297543</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2001 Aug 10;276(32):30374-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11397793</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chem Biol. 2001 Aug;8(8):759-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11514225</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2001 Sep 21;276(38):35693-700</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11479295</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochemistry. 2001 Nov 27;40(47):14134-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11714266</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2001 Dec 21;276(51):47763-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11684673</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2003 Jan 3;278(1):679-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12409293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Mol Med. 2003 Apr 30;35(2):61-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12754408</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2003 Jun 5;423(6940):655-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12789342</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2003 Jun 5;423(6940):659-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12789343</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2003 Nov 7;278(45):44091-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12939259</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antioxid Redox Signal. 2004 Feb;6(1):63-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14713336</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2004 Mar;4(3):181-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15039755</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2004 Apr 23;304(5670):596-600</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15105503</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8945-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15184672</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochemistry. 1993 Apr 6;32(13):3368-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8461300</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochemistry. 1996 Feb 20;35(7):2482-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8652592</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 1996 Jun 15;24(12):2236-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8710491</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 1997 Aug;151(2):389-401</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9250152</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1997 Aug 7;388(6642):548-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9252186</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 1997 Oct 31;278(5339):860-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9346484</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1998 Sep 17;395(6699):297-300</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9751060</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochemistry. 1998 Dec 8;37(49):17145-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9860827</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 1999 Apr 9;284(5412):309-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10195894</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 1999 Apr 9;284(5412):271-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10232975</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FASEB J. 1999 Sep;13(12):1481-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10463938</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2004 Nov;10(11):1200-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15489859</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2004 Dec 3;279(49):50994-1001</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15448164</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2005 Feb 4;280(5):3125-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15590625</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):348-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15706083</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta. 2006 Mar;1760(3):380-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16515838</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochemistry. 2004 Sep 28;43(38):12177-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15379556</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 2000 Jun 30;476(1-2):52-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10878249</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Guala, Amy S" sort="Guala, Amy S" uniqKey="Guala A" first="Amy S" last="Guala">Amy S. Guala</name>
<name sortKey="Heim, John" sort="Heim, John" uniqKey="Heim J" first="John" last="Heim">John Heim</name>
<name sortKey="Heintz, Nicholas H" sort="Heintz, Nicholas H" uniqKey="Heintz N" first="Nicholas H" last="Heintz">Nicholas H. Heintz</name>
<name sortKey="Ho, Ye Shih" sort="Ho, Ye Shih" uniqKey="Ho Y" first="Ye-Shih" last="Ho">Ye-Shih Ho</name>
<name sortKey="Hristova, Milena" sort="Hristova, Milena" uniqKey="Hristova M" first="Milena" last="Hristova">Milena Hristova</name>
<name sortKey="Janssen Heininger, Yvonne M W" sort="Janssen Heininger, Yvonne M W" uniqKey="Janssen Heininger Y" first="Yvonne M W" last="Janssen-Heininger">Yvonne M W. Janssen-Heininger</name>
<name sortKey="Matthews, Dwight E" sort="Matthews, Dwight E" uniqKey="Matthews D" first="Dwight E" last="Matthews">Dwight E. Matthews</name>
<name sortKey="Mcgovern, Toby" sort="Mcgovern, Toby" uniqKey="Mcgovern T" first="Toby" last="Mcgovern">Toby Mcgovern</name>
<name sortKey="Pantano, Cristen" sort="Pantano, Cristen" uniqKey="Pantano C" first="Cristen" last="Pantano">Cristen Pantano</name>
<name sortKey="Van Der Vliet, Albert" sort="Van Der Vliet, Albert" uniqKey="Van Der Vliet A" first="Albert" last="Van Der Vliet">Albert Van Der Vliet</name>
<name sortKey="Wouters, Emiel F M" sort="Wouters, Emiel F M" uniqKey="Wouters E" first="Emiel F M" last="Wouters">Emiel F M. Wouters</name>
</noCountry>
<country name="États-Unis">
<noRegion>
<name sortKey="Reynaert, Niki L" sort="Reynaert, Niki L" uniqKey="Reynaert N" first="Niki L" last="Reynaert">Niki L. Reynaert</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/GlutaredoxinV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D56 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D56 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    GlutaredoxinV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:16916935
   |texte=   Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:16916935" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GlutaredoxinV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 15:13:42 2020. Site generation: Wed Nov 18 15:16:12 2020